Showing results (461-470 of 485) with videos related to
Sort By:
Pageof 49
Blood Immunology & Cellular Therapy|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRMYu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.Leukemia|May 4, 2018
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trialPeter Paschka, Richard F Schlenk, Daniela Weber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2017
Intestinal Microbiota and Relapse After Hematopoietic-Cell TransplantationJonathan U Peled, Sean M Devlin, Anna Staffas, et al.Nature|October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycinAdrianna M Turner, Lucy Li, Ian R Monk, et al.Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.Transplantation and Cellular Therapy|September 27, 2025
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease SeverityIoannis Evangelos Louloudis, Yi-Bin Chen, Nikolaos Spyrou, et al.Blood|December 20, 2018
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITDRichard F Schlenk, Daniela Weber, Walter Fiedler, et al.Pageof 49